Sophie Grice

Liverpool, ENG L693GE, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

In-Vitro Generation of T-Cell Clones to Difluorophenylglyoxal: Implications for Understanding the Immunogenicity of MK-3207.

In-Vitro Generation of T-Cell Clones to Difluorophenylglyoxal: Implications for Understanding the Immunogenicity of MK-3207.

Journal: Chemical research in toxicology

Published: May 22, 2026

Omeprazole activation of CD4+ and CD8+ T-cells through off-target covalent modification of cellular proteins.

Omeprazole activation of CD4+ and CD8+ T-cells through off-target covalent modification of cellular proteins.

Journal: Toxicological sciences : an official journal of the Society of Toxicology

Published: April 27, 2026

Covalent binding of flucloxacillin to 14-3-3 proteins promotes naive T-cell activation.

Covalent binding of flucloxacillin to 14-3-3 proteins promotes naive T-cell activation.

Journal: The Journal of allergy and clinical immunology

Published: November 20, 2025

Immune checkpoint blockade lowers the threshold of naïve T-cell priming to drug-associated antigens in a dose-dependent fashion.

Immune checkpoint blockade lowers the threshold of naïve T-cell priming to drug-associated antigens in a dose-dependent fashion.

Journal: Toxicological sciences : an official journal of the Society of Toxicology

Published: September 18, 2024

Omeprazole-Associated Atypical Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in a Patient with Positive In Vitro Diagnostic Testing to Multiple Proton Pump Inhibitors.

Omeprazole-Associated Atypical Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in a Patient with Positive In Vitro Diagnostic Testing to Multiple Proton Pump Inhibitors.

Journal: Chemical research in toxicology

Published: September 04, 2024

Immunological Drug-Drug Interactions Affect the Efficacy and Safety of Immune Checkpoint Inhibitor Therapies.

Immunological Drug-Drug Interactions Affect the Efficacy and Safety of Immune Checkpoint Inhibitor Therapies.

Journal: Chemical research in toxicology

Published: June 24, 2024

Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines.

Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines.

Journal: NPJ vaccines

Published: January 09, 2024

Investigating the Immune Basis of Green Tea Extract Induced Liver Injury in Healthy Donors Expressing HLA-B*35:01.

Investigating the Immune Basis of Green Tea Extract Induced Liver Injury in Healthy Donors Expressing HLA-B*35:01.

Journal: Chemical research in toxicology

Published: December 06, 2023

HLA-C*15:02 and epidermal growth factor receptor inhibitor-induced erosive pustular dermatosis of the scalp.

HLA-C*15:02 and epidermal growth factor receptor inhibitor-induced erosive pustular dermatosis of the scalp.

Journal: Clinical and experimental dermatology

Published: March 08, 2023

Does immune checkpoint inhibitor therapy increase the frequency of adverse reactions to concomitant medications?

Does immune checkpoint inhibitor therapy increase the frequency of adverse reactions to concomitant medications?

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: February 09, 2022

Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity.

Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity.

Journal: Toxicological sciences : an official journal of the Society of Toxicology

Published: December 01, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026